Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Qosina announced that it has entered into a distribution agreement with Nordson MEDICAL, a manufacturer and supplier of components to the bioprocess and medical device industries. Qosina offers low minimum order quantities, providing a cost-effective...
read more
Cambrex announced the completion of an investment project at its facility in Tallinn, Estonia to upgrade its kilogram-scale laboratory to undertake the manufacture of pharmaceutical intermediates under current good manufacturing practice (CGMP) ...
read more
The second week of CPhI Discover is open amid news that both the Italian and French governments have confirmed they will allow trade shows to resume – providing formal confirmation for both CPhI Worldwide and Pharmapack Europe.
read more
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, announced that John Cullivan has joined the Company as a new member of the executive leadership team as Chief Corporate Development ...
read more
Novatek requalified as an approved supplier for Boehringer Ingelheim, a global leader in healthcare. Novatek regulatory compliant quality solutions are used at Boehringer Ingelheim for its human pharma, animal health and biopharmaceutical aseptic ...
read more
Adare Pharma Solutions announced it has strengthened its executive leadership team with two key hires. Robert Muschert has joined Adare as Chief Commercial Officer, and Dr. Vipan Dhall has joined as Chief Scientific Officer.
read more
To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, MilliporeSigma has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule. “Tapping into two decades’ experience of ...
read more
ProBioGen and Minapharm Pharmaceuticals announce the incorporation of ProBioGen's subsidiary "MiGenTra" with headquarters in Berlin and access to a site in Cairo, which will house its principal manufacturing plant. MiGenTra will enhance the ...
read more
Inotiv, a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, announced that the Company has completed the purchase of its previously leased St. Louis facility for approximately $...
read more
Spaulding Clinical, a full-service Phase I clinical service provider, announced expanded services for clinical trial Phases I through III, including biometrics, data management, and medical writing. While approaching their 15th anniversary and ...
read more
Hovione was a founding member of iBET in 1989 and has just re-joined the Instituto de Biologia Experimental e Tecnológica. In order to increase the scope and strength of its research and development programs in the areas of novel and high potential ...
read more
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, will open its expanded production facilities in Ajdovscina, Slovenia. The area for manufacturing and labs will increase from 3,000 square meters ...
read more
The agreement with the U.S. Department of Health and Human Services, in coordination with the U.S. Department of Defense (DOD), will expand testing opportunities in K-8 schools, underserved populations and congregate settings such as homeless ...
read more
SOFIE, an established Radiopharmaceutical Contract Manufacturing Organization and GMP radiopharmacy network, will be commercially manufacturing and distributing PYLARIFY®(piflufolastat F 18) injection, an F 18-labeled prostate-specific membrane ...
read more
Aptamer Group, the developer of diagnostic and therapeutic Optimer™ reagents, announced that it has signed an agreement with the multinational pharmaceutical and biopharmaceutical company Takeda Pharmaceutical Company Limited (“Takeda”).
read more